Overview

LEV102 Topical Gel in Acquired Blepharoptosis

Status:
Not yet recruiting

Trial end date:
2023-09-30

Target enrollment:

Participant gender:

Summary

Phase 1/2a, multicenter, randomized, vehicle-controlled, double-masked, multiple-dose, parallel-group study conducted in adult subjects with acquired blepharoptosis.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Levation Pharma, Ltd.